ICON experts frequently author or contribute to industry trade press. The following are some recent articles.
Decentralised Clinical Trials and Real World Evidence
In this video interview, Kim Boericke, President, Commercialization and Outcomes Services, discusses what is driving a great focus and intensity on outcomes in clinical trials, trends coming in 2022, and the use of real-world data in the rare disease space.
The growing potential of neurological biomarkers as surrogate endpoints for accelerated drug development
This article by Dr. Peter Schueler explores how digital and liquid biomarkers are developing, and how they can impact the future of neurological studies.
ICON expands Accellacare Site Network
An article reporting on ICON's recent announcement that its Accellacare Site Network has entered new partnerships with six research sites across four countries, expanding its global footprint and capabilities.
Clinical research heroes: Mitsu Rana
Mitsu Rana, Senior Director of Project Management, share her perspective on the current state of clinical research and how it is adapting.
Glycomics applications reinforce precision medicine
Nicole A. Cowan explores how glycomics is joining genomics and proteomics in the study of disease mechanisms and the development of novel therapeutics.
The path to smarter digital health
Michael Phillips and Kevin Rooney discuss the use of artificial intelligence for the purposes of automation in digital health and pharma.
Clinical Researcher of the Year - The Americas 2021 winners announced
The evening was particularly successful for ICON plc, which won the coveted Clinical Research Company of the Year award for having the most successful finalists throughout the competition.
Video series: The 3 "Cs" of the data journey
This three part video series examines some of the factors that should be considered to ensure that clinical trial data captured via wearable devices, is monitored expeditiously and effectively.
Bringing the fight to antimicrobial resistance: What COVID-19 has taught us about how to face a growing emergency
Dr. Johan Du Toit, Executive Director, Internal Medicine, considers strategies from COVID era clinical trials for addressing the public health crisis of antimicrobial resistance.
ICON Q&A: talking affordability in cell and gene therapies
Tamie Joeckel discusses the challenges of making cell and gene therapies affordable for payers and patients alike.